Nanovibronix Inc
Change company Symbol lookup
Select an option...
NAOV Nanovibronix Inc
ETON Eton Pharmaceuticals Inc
LXRX Lexicon Pharmaceuticals Inc
BVS Bioventus Inc
TDS-U Telephone and Data Systems Inc
ELEV Elevation Oncology Inc
FRZA Forza X1 Inc
SIEN Sientra Inc
PMGM Priveterra Acquisition Corp
NVFY Nova LifeStyle Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Health Care Equipment & Supplies | Small Cap Value

NanoVibronix, Inc. is a medical device company. The Company is focused on developing noninvasive biological response-activating devices utilizing its low-intensity surface acoustic wave (SAW) technology. Its primary products consist of UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use, which markets in the United States under Food and Drug Administration (FDA) policy of enforcement discretion during the COVID-19 pandemic and is undergoing clinical testing. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. Its PainShield family of products includes PainShield MD and PainShield Plus.

Price: Delayed
$3.33

Day's Change: -0.1377 (-3.97%)

Bid: --

Ask: --

B/A Size: --

Day's High: 3.36

Day's Low: 3.33

Volume (Average) Today's volume of 1,169 shares is on pace to be in-line with NAOV's 10-day average volume of 6,672 shares.: 1,169

MetLife Inc. Stock Rises Friday, Outperforms Market

5:09 pm ET February 24, 2023 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of MetLife Inc. (MET) rallied 1.79% to $71.84 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 1.05% to 3,970.04 and Dow Jones Industrial Average falling 1.02% to 32,816.92. The stock's rise snapped a three-day losing streak. MetLife Inc. closed $5.52 below its 52-week high ($77.36), which the company reached on November 25th.

Trading volume (5.2 M) eclipsed its 50-day average volume of 3.8 M.

Data source: Dow Jones Market Data, FactSet. Data compiled February 24, 2023.

(END) Dow Jones Newswires

February 24, 2023 17:09 ET (22:09 GMT)

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and